期刊文献+

丙戊酸镁干预对癫痫幼鼠海马区B1及B2激肽受体表达的影响 被引量:3

The effects of magnesium valproate on expression of the kinin B1 and B2 receptors in the hippocampus of the juvenile rats submitted to pilocarpine model of epilepsy
原文传递
导出
摘要 目的观察丙戊酸镁对氯化锂一匹罗卡品癫痫幼鼠模型海马区B1及B2激肽受体表达的影响并探讨其作用机理。方法健康幼鼠35只,采用氯化锂一匹罗卡品腹腔注射法制作癫痫模型,癫痫模型干预组15只,分为急性期丙戊酸镁干预组(12h,I组)、静止期丙戊酸镁干预组(5d,II组)、慢性期丙戊酸镁干预组(60d,Ⅲ组),每组5只;癫痫模型无干预组15只,分为急性期无干预组(6h,Ia组),静止期无干预组(5d,IIa组),慢性期无干预组(60d,Ⅲa组),每组5只;设置空白对照组5只(Ⅳ组)。丙戊酸镁均经鼻饲管给药,在干预后的相应时间点处死动物取海马标本,应用逆转录聚合酶链反应(RT.PCR)及westernblot方法分别检测各组动物不同时间点海马区的B1及B2激肽受体的表达变化,并相互进行此较。结果给予丙戊酸镁干预后,与Ia组(0.76±0.068、0.89±0.034;0.28±0.034、0.32±0.039)比较,I组B1激肽受体mRNA(0.38±0.051)及蛋白质表达(0.58±0.057)均显著下调,差异有统计学意义(P〈0.05),I组B2激肽受体mRNA(0.48±0.056)及蛋白质表达(0.48±0.044)均显著上调,差异有统计学意义(P〈0.05);与IIa组(0.58±0.059、0.69±0.046;0.47±0.046、0.58±0.052)比较,Ⅱ组B1激肽受体mRNA(0.23±0.044)及蛋白质表达(0.394-0.034)显著下调,差异有统计学意义(P〈0.05),B2激肽受体mRNA(0.69±0.063)及蛋白质表达(0.794-0.063)显著上调,差异有统计学意义(P〈0.05);与Ⅲa组(0.70±0.052、0.80±0.048)比较,Ⅲ组B2激肽受体mRNA(0.89±0.031)及蛋白质表达(0.91±0.031)显著上调,差异有统计学意义(P〈0.05);与对照组比较,B1及B2激肽受体蛋白质表达Ia组、IIa组均显著增高,差异有统计学意义(P〈0.05),Ⅲa组B2激肽蛋白质表达(0.80±0.048)亦显著上调,差异有统计学意义(P〈0.05)。结论丙戊酸镁能降低海马区B1激肽受体表达,上调B2激肽受体表达,其保护机制与B激肽受体表达有关。 Objective To investigate the mechanisms and the effects of magnesium Valproate on the ex- pressions of the kinin B1 and B2 receptors in the hippocampus of the juvenile rats submitted to pilocarpine model of epilepsy. Methods 35 healthy Wistar juvenile rats were randomly divided into six groups, that is the model groups : I group, Ⅱgroup, i group, and intraperitoneal injection of saline water control groups : I a group, Ⅱ a group, llIa group , after succession of 15 rats to kindle to establish the model of epilepsy by pilocarpine. To collect hippocampus tissue after the rats were to put to death, and to compared the expression levels of kinin B1 and B2 receptor mRNA by RT-PCR and western blot in the hippoeampus of rats. Results By treated with magnesium val- proate, kinin B1 receptor mRNA (0.38 ±0. 051 )and protein expressions(0.58 ±0. 057 )decreased and kinin B2 reeeptor mRNA (0.48± 0.056 ) and protein expressions (0.48 ±0. 044 ) increased in [ group, compared with that (0.76±0.068,0.89±0.034;0.28 ±0.034,0.32±0.039) of I agroup(P〈0.05). Compared with control group, there were more signifieant upregulation of kinin B1 receptor mRNA and protein expressions (P 〈 0.05 ) in the I and the Ⅱ groups and there were no alteration in Ill group. The expressional levels of B2 receptor mRNA and protein were upregulated in the Ⅰ , Ⅱ andⅢ groups. Conclusion The kinin B1 and B2 receptor may play a role in the onset and maintenance of epilepsy. The magnesium valproate increased the expressional levels of kinin B2 reeeptor,and decreased the expressional levels of kinin B1 receptor.
出处 《中华行为医学与脑科学杂志》 CAS CSCD 北大核心 2012年第4期324-326,共3页 Chinese Journal of Behavioral Medicine and Brain Science
基金 基金项目:郑州市科技攻关计划(083sGYG26122-9) 郑州大学博士后资助计划(8069)
关键词 B激肽受体 丙戊酸镁 匹罗卡品 癫痫模型 Kinin B receptor Magnesium valproate Epilepsy model Pilocarpine
  • 相关文献

参考文献2

二级参考文献13

  • 1王建平,曹亚芹,苏怡凡.癫癎患儿外周血单个核细胞NF-κb活化的变化[J].中国当代儿科杂志,2009,11(1):44-46. 被引量:10
  • 2Racine RJ.Modification of seizure activity by electrical stimulation:Ⅱ.Motor seizure[J].Electroencephalogr.Clin Neurophysiol,1972,32:281-294.
  • 3Arganraz GA,Silva Jr JA,Perosa SR,et al.The synthesis and distribution of the kinin B1 and B2 receptors are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy[J].Brain Res,2004,1006:114-125.
  • 4Volk HA,Arabadzisz D,Fritschy JM,et al.Antiepileptic drug-resistant rats differ from drug-responsive rats in hippocampal neurodegeneration and GABA receptor ligand binding in a model of temporal lobe epilepsy[J].Neurobiol Dis,2006,21:633-646.
  • 5Adolfo AG,Regina PS,Cristina LE,et al.Role of kinin B1 and B2 receptors in the development of pilocarpine model of epilepsy[J].Brain Res,2004,1013:30-39.
  • 6Felipe SA,Rodrigues ES,Marein RP,et al.Functional expression of kinin B1 and B2 receptors in mouse abdominal aorta[J].J Med Biol Res,2007,40:649-655.
  • 7Bregola G,Varani K,Beani C,et al.Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy[J].Neuroscience,1999,92:1043-1049.
  • 8Ongali B,Campos MM,Bregola G,et al.Autoradiographic analysis of rat brain kinin B1 and B2 receptors:normal distribution and alterations induced by epilepsy[J].Comp Neurol,2003,461:506-519.
  • 9Mazzuferi M,Binaschi A,Rodi D,et al.Induction of B1 bradykinin receptors in the kindled hippocampus increases extracellular glutamate levels:a microdialysis study[J].Neuroscience,2005,135:979-986.
  • 10Arganaraz CA,Perosa SR.Role of kinin B1 and B2 receptors in the development of pilocarpine model of epilepsy[J].Brain Res,2004,1006:114-125.

共引文献9

同被引文献59

  • 1朱凤,徐贵法,刘铁.瘦素的分泌及其影响因素[J].中国公共卫生,2004,20(1):49-50. 被引量:7
  • 2何艳,赵峥,郭田荣,王夏红,穆俊林.癫患儿服用丙戊酸镁缓释片治疗前后认知功能的变化[J].实用儿科临床杂志,2006,21(24):1730-1731. 被引量:1
  • 3Hanyaloglu AC,yon Zastrow M.Regulation of GPCRs by endocytic membrane trafficking and its potential implications[J].Annu Rev Pharmacol Toxico1,2008,48:537-568.
  • 4Marchese A,Paing MM,Temple BR,et al.G protein-coupled receptor sorting to endosomes and lysosomes[J].Annu Rev Pharmacol Toxicol,2008,48:601-629.
  • 5Garcia-Santisteban I,Peters GJ,Giovannetti E,et al.USP1 deubiquitinase:cellular functions,regulatory mechanisms and emerging potential as target in cancer therapy[J].Mol Cancer,2013,12:91.
  • 6Komander D,Rape M.The ubiquitin code[J].Annu Rev Biochem,2012,81:203-229.
  • 7Kulathu Y,Komander D.Atypical ubiquitylation-the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages[J].Nat Rev Mol Cell Biol,2012,13(8):508-523.
  • 8Matsumoto ML,Wickliffe KE,Dong KC,et al.K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific anti-body[J].Mol Cell,2010,39(3):477-484.
  • 9Chastagner P,Isra?惊 1 A,Brou C.AIP4/Itch regulates Notch receptor degradation in the absence of ligand[J].PLoS One,2008,3 (7):e2735.
  • 10Dammer EB,Na CH,Xu P,et al.Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease[J].J Biol Chem,2011,286(12):10457-10465.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部